What is the most likely diagnosis and appropriate management for a 15-year-old female with low serum iron and microcytic hypochromic anemia (MCV 66 fL, MCH 20.8 pg, RDW 16.6)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Iron Deficiency Anemia in a 15-Year-Old Female

This 15-year-old female has iron deficiency anemia (IDA), and she should begin oral ferrous sulfate 200 mg (65 mg elemental iron) three times daily immediately. 1

Diagnostic Confirmation

The laboratory findings definitively establish iron deficiency anemia:

  • Microcytic hypochromic anemia with MCV 66.2 fL (markedly below normal 80 fL threshold), MCH 20.8 pg, and 2+ hypochromasia and microcytosis on peripheral smear 2, 3
  • Low serum iron of 45 µg/dL confirms inadequate iron availability 3, 1
  • Elevated RDW of 16.6% (>14%) indicates increased red cell size variation, which strongly supports IDA rather than thalassemia trait when combined with low MCV 3, 4
  • Serum ferritin should be obtained if not already done, as it is the single most useful marker for confirming iron deficiency, with levels <15 µg/L being diagnostic 2, 1

The combination of low MCV, low MCH, elevated RDW >14%, and low serum iron creates a pattern that strongly distinguishes IDA from thalassemia trait, which typically shows normal RDW 3, 4.

Immediate Treatment Protocol

Start oral iron supplementation now:

  • Ferrous sulfate 200 mg (65 mg elemental iron) three times daily is first-line therapy and most cost-effective 1
  • Alternative dosing: 3-6 mg/kg/day of elemental iron if the standard dose is not tolerated 1, 5
  • Add vitamin C (ascorbic acid) to enhance iron absorption 1
  • Encourage heme iron from meat sources over plant-based non-heme iron for better absorption 1

Monitoring Response

Follow-up schedule:

  • Check hemoglobin at 2 weeks to confirm response (expect ≥10 g/L rise, which confirms IDA even if initial iron studies were equivocal) 2, 1
  • Monitor hemoglobin every 3 months for one year, then annually 1
  • Continue iron therapy for 3 months after anemia correction to replenish iron stores 1

Identify Underlying Cause

In adolescent females, the most common causes are:

  • Menstrual blood loss (most common in this age group) 1
  • Inadequate dietary iron intake 1
  • Increased physiological demands from growth and athletic activity 1

Evaluate for:

  • Menstrual history (heavy or prolonged periods)
  • Dietary assessment (vegetarian diet, inadequate meat intake)
  • Athletic participation
  • Gastrointestinal symptoms suggesting malabsorption or bleeding 2

When to Consider Alternative Therapy

Parenteral iron is reserved for:

  • Intolerance to at least two oral iron preparations
  • Non-compliance with oral therapy
  • Intestinal malabsorption
  • Anemia refractory to oral supplementation 1

Critical Pitfalls to Avoid

Do not delay treatment while waiting for ferritin results—the clinical picture is diagnostic, and a good response to iron therapy (Hb rise ≥10 g/L within 2 weeks) confirms IDA retrospectively 2.

Do not perform hemoglobin electrophoresis in this case—the elevated RDW >14% with microcytosis indicates IDA, not thalassemia trait, which typically shows normal RDW 3, 4. Hemoglobin electrophoresis is only indicated when microcytosis occurs with normal iron studies 2.

Do not stop iron therapy when hemoglobin normalizes—continue for 3 additional months to replenish iron stores 1.

References

Guideline

Management of Iron Deficiency in Adolescent Females

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Iron Deficiency Anemia: Diagnostic Parameters

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Iron Deficiency Anemia: An Updated Review.

Current pediatric reviews, 2024

Related Questions

What is the most appropriate initial treatment for a patient with microcytic anemia, MCV of 74.7, MCH of 21.6, RDW of 14.3, Hgb A2 of 2.1, and a ferritin level of 38?
What additional tests are required for a patient with microcytic anemia who has not responded to iron supplementation (ferrous sulfate)?
What work‑up and management are indicated for a 46‑year‑old woman with microcytic anemia (MCV 69 fL), high red cell distribution width (RDW 20.7 %), normal mean corpuscular hemoglobin concentration (MCHC 30.6 g/dL), elevated alkaline phosphatase, mildly elevated aspartate aminotransferase (AST 45 U/L) and alanine aminotransferase (ALT 43 U/L), hypercholesterolemia (total cholesterol 272 mg/dL), hypertriglyceridemia (triglycerides 228 mg/dL), elevated low‑density lipoprotein (LDL 131 mg/dL), and pre‑diabetes (hemoglobin A1c 6.0 %)?
What is the appropriate management for a patient with microcytic anemia, elevated ferritin, low iron, and low TIBC, suggesting anemia of chronic disease?
What is the diagnosis for a patient with microcytic anemia, normal ferritin (iron storage protein) levels, and elevated transferrin (transport protein)?
What are the appropriate next medication options for treating depression in a patient already taking escitalopram (Lexapro) who cannot use bupropion (Wellbutrin)?
In a patient with documented moderate to severe hypophosphatemia (serum phosphate <2.5 mg/dL) or symptomatic hypophosphatemia, when should phosphate be replaced and what are the recommended oral versus intravenous dosing and monitoring guidelines?
Is vasculitis considered a rheumatologic disorder?
In an asymptomatic patient without urinary catheter or other risk factors, is methicillin‑resistant Staphylococcus epidermidis isolated from a urine culture considered a contaminant?
What is the significance of finding 3–5 red blood cells per high‑power field on urine microscopy, and how should microscopic hematuria be evaluated in an adult?
Can an otherwise healthy adult patient who started Lexapro (escitalopram) 10 mg today and now has three days of nausea, vomiting, dry retching, diarrhea and intermittent hot‑cold sensations, without fever, allergies, QT‑prolongation risk or pregnancy, be safely prescribed ondansetron and receive a medical certificate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.